4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Xenogeneic materials for the surgical treatment of aortic infections

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The surgical treatment of aortic infections (AIs) is challenging. In situ aortic reconstructions represent nowadays the favored therapy for fit patients and xenogeneic materials are used increasingly. The aim of this study was to present our experience with xenogeneic reconstructions for AI using self-made bovine pericardium tubes and/or the biosynthetic Omniflow ® II graft.

          Methods

          This retrospective single-center study included all patients undergoing xenogeneic aortic and aortoiliac reconstructions from December 2015 to June 2020. Patient comorbidities, symptoms, procedural characteristics, types of pathogens and postoperative outcomes were analyzed.

          Results

          Twenty-eight patients [23 male (82%), median age 68 (range, 28–84) years] were included. Ten patients (36%) had native AIs and 18 (64%) had graft infections, including 3 (11%) aortoesophageal and 2 (7%) aortoduodenal fistulas (ADF). Twenty-four patients (86%) were symptomatic, the most common symptoms being contained aortic rupture (n=8) and sepsis (n=4). The surgical procedures were infra- and juxtarenal aortic repairs (n=11, 39% and n=7, 25%), thoracoabdominal aortic repairs (type IV: n=1, 4%; type V: n=3, 11%), descending thoracic aortic repairs (n=4, 14%) and 2 reconstructions (7%) involving the ascending aorta/aortic arch. Most were urgent (n=10, 43%) or emergent operations (n=11, 35%). Identification of pathogen(s), mostly Gram-positive bacteria, was possible in 25 patients (89%). Twelve patients (43%) had polymicrobial infections and 6 (21%) infections with multi-resistant bacteria. In-hospital mortality was 32% (n=9) due to acute cardiac failure (1/9), endocarditis (1/9), bleeding (3/9) and sepsis (4/9). The most frequent complications were transient need for dialysis (n=12, 43%) and persisting sepsis (n=11, 39%). Two early occlusions of Omniflow ® II grafts were observed (7%). Median follow-up (FU), during which 2 patients died of non-aortic causes, was 14 months (95% CI: 9–19 months). Freedom from reoperation was 100%, there was no evidence for reinfection during FU.

          Conclusions

          Xenogeneic orthotopic reconstructions for AI can be performed at all aortic levels. Combining bovine pericardium and the Omniflow ® II graft can be useful for reconstructing the branched aortic segments and both materials show appropriate early to midterm outcomes. Nonetheless, AIs are serious conditions associated with relevant morbidity/mortality rates, even in a specialized center.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: not found
          • Article: not found

          A note on quantifying follow-up in studies of failure time.

            • Record: found
            • Abstract: not found
            • Article: not found

            Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections

              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC).

              The management of aortic graft infection (AGI) is highly complex and in the absence of a universally accepted case definition and evidence-based guidelines, clinical approaches and outcomes vary widely. The objective was to define precise criteria for diagnosing AGI.

                Author and article information

                Journal
                J Thorac Dis
                J Thorac Dis
                JTD
                Journal of Thoracic Disease
                AME Publishing Company
                2072-1439
                2077-6624
                May 2021
                May 2021
                : 13
                : 5
                : 3021-3032
                Affiliations
                [1 ]deptEuropean Vascular Center Aachen-Maastricht, Department of Vascular Surgery , RWTH University Hospital Aachen , Aachen, Germany;
                [2 ]deptEuropean Vascular Center Aachen-Maastricht, Department of Vascular Surgery , AZM University Hospital Maastricht , Maastricht, The Netherlands
                Author notes

                Contributions: (I) Conception and design: PR Keschenau, D Kotelis; (II) Administrative support: A Gombert, MJ Jacobs, H Jalaie, J Kalder; (III) Provision of study materials or patients: MJ Jacobs, H Jalaie, J Kalder, D Kotelis; (IV) Collection and assembly of data: PK Keschenau; (V) Data analysis and interpretation: PR Keschenau, A Gombert, ME Barbati; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

                Correspondence to: Michael J. Jacobs, MD, PhD. European Vascular Center Aachen-Maastricht, Department of Vascular Surgery, RWTH University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. Email: mjacobs@ 123456ukaachen.de .
                [^]

                ORCID: Paula R. Keschenau, 0000-0002-2823-8091; Johannes Kalder, 0000-0002-0606-2814.

                Article
                jtd-13-05-3021
                10.21037/jtd-20-3481
                8182519
                34164193
                29b0ed67-74b9-4072-ac46-63e24f590108
                2021 Journal of Thoracic Disease. All rights reserved.

                Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

                History
                : 10 December 2020
                : 14 March 2021
                Categories
                Original Article

                aneurysm,infected,prosthesis-related infections,bioprosthesis,vascular grafting,transplants

                Comments

                Comment on this article

                Related Documents Log